6 research outputs found

    Cell wall damage followed by remodeling occurs during adaptation to 5-flucytosine stress.

    No full text
    <p>A) <i>C</i>. <i>glabrata</i> KUE100 cells exposed to lyticase stress were harvested in the exponential phase of growth in the absence of stress (♦) or upon 30 min of exposure to 0.7 mg/L 5-flucytosine (■), or in the exponential phase of growth reached upon adaptation to 0.7 mg/L 5-flucytosine (▲). The different cell populations were washed with water and resuspended in 0.1M sodium phosphate buffer at pH 7.5. After addition of 20mg/L lyticase, the decrease in the OD<sub>600nm</sub> of the cell suspension was measured periodically and indicated as a percentage of the initial OD<sub>600nm</sub>. The indicated values are averages of at least three independent experiments. Error bars represent the corresponding standard deviation. * P<0.05; ***P<0.001. B) Comparison, by spot assays, of the susceptibility of <i>C</i>. <i>glabrata</i> KUE100 cells harvested in the exponential phase of growth in the absence of stress (control) or upon 30 min of exposure to 0.5 mg/L 5-flucytosine (30’ 5-FC), or in the exponential phase of growth reached upon adaptation to 0.5 mg/L 5-flucytosine (exp 5-FC) to Calcofluor White, in MMB agar plates. The inocula were prepared as described in Materials and Methods, and the cell suspensions used to prepare the spots 1:5 (b) and 1:25 (c) dilutions of the cell suspension used for column a. The images are representative of at least three independent experiments.</p

    New Mechanisms of Flucytosine Resistance in <i>C</i>. <i>glabrata</i> Unveiled by a Chemogenomics Analysis in <i>S</i>. <i>cerevisiae</i>

    No full text
    <div><p>5-Flucytosine is currently used as an antifungal drug in combination therapy, but fungal pathogens are rapidly able to develop resistance against this drug, compromising its therapeutic action. The understanding of the underlying resistance mechanisms is crucial to deal with this problem. In this work, the <i>S</i>. <i>cerevisiae</i> deletion mutant collection was screened for increased resistance to flucytosine. Through this chemogenomics analysis, 183 genes were found to confer resistance to this antifungal agent. Consistent with its known effect in DNA, RNA and protein synthesis, the most significant Gene Ontology terms over-represented in the list of 5-flucytosine resistance determinants are related to DNA repair, RNA and protein metabolism. Additional functional classes include carbohydrate and nitrogen—particularly arginine—metabolism, lipid metabolism and cell wall remodeling. Based on the results obtained for <i>S</i>. <i>cerevisiae</i> as a model system, further studies were conducted in the pathogenic yeast <i>Candida glabrata</i>. Arginine supplementation was found to relieve the inhibitory effect exerted by 5-flucytosine in <i>C</i>. <i>glabrata</i>. Lyticase susceptibility was found to increase within the first 30min of 5-flucytosine exposure, suggesting this antifungal drug to act as a cell wall damaging agent. Upon exponential growth resumption in the presence of 5-flucytosine, the cell wall exhibited higher resistance to lyticase, suggesting that cell wall remodeling occurs in response to 5-flucytosine. Additionally, the aquaglyceroporin encoding genes <i>CgFPS1</i> and <i>CgFPS2</i>, from <i>C</i>. <i>glabrata</i>, were identified as determinants of 5-flucytosine resistance. <i>CgFPS1</i> and <i>CgFPS2</i> were found to mediate 5-flucytosine resistance, by decreasing 5-flucytosine accumulation in <i>C</i>. <i>glabrata</i> cells.</p></div

    The acquaglyceroporins CgFps1 and CgFps2 confer resistance to 5-flucytosine.

    No full text
    <p><b>A)</b> Comparison, by spot assays, of the susceptibility of the <i>C</i>. <i>glabrata</i> KUE100, KUE100_<i>Δcgfps1</i> and KUE100_<i>Δcgfps2</i> strains (B) to 5-flucytosine, in MMB agar plates. <b>B)</b> Fluorescence of exponential-phase BY4741 <i>S</i>. <i>cerevisiae</i> cells, harboring the cloning vector pGREG576 (control) or the pGREG576_<i>CgFPS1</i> plasmids (CgFps1_GFP), after 5h of galactose-induced recombinant protein expression. <b>C)</b> Comparison, by spot assays, of the susceptibility to 5-flucytosine of <i>S</i>. <i>cerevisiae</i> BY4741 and BY4741_<i>Δfps1</i> cells, harboring the cloning vector pGREG576 (v) or the same plasmid expressing the <i>CgFPS1</i> gene, in MMB agar plates. In A) and C) the inocula were prepared as described in Materials and Methods, and the cell suspensions used to prepare the spots 1:5 (b) and 1:25 (c) dilutions of the cell suspension used for column a. The images are representative of at least three independent experiments.</p

    <i>CgFPS1</i> and <i>CgFPS2</i> expression decreases the accumulation of 5-flucytosine in <i>C</i>. <i>glabrata</i> cells.

    No full text
    <p>Time-course accumulation of [<sup>3</sup>H]-flucytosine in non-adapted KUE100 (♦), KUE100_<i>Δcgfps1</i> (■) and KUE100_<i>Δcgfps2</i> (▲) strains, during cultivation in BM liquid medium in the presence of 3mg/L of unlabelled 5-flucytosine. The indicated accumulation ratio values are averages of at least three independent experiments. Error bars represent the corresponding standard deviation. * P<0.05; **P<0.01.</p

    Arginine supplementation decreases the inhibitory effect exerted by 5-flucytosine in <i>C</i>. <i>glabrata</i>.

    No full text
    <p>The growth curves of parental <i>C</i>. <i>glabrata</i> KUE100 cells in the absence (□,◊) or presence (■,♦) of 0.5 mg/L 5-flucytosine are compared, upon supplementation (◊,♦) or not (□,■) with 60mg/L arginine. The displayed growth curves are the average of three independent experiments. Error bars represent the corresponding standard deviation. **indicates that there is a statistically significant (P<0.01) difference between the OD<sub>600nm</sub> reached in the presence and absence of arginine, at the indicated times points.</p

    Distribution into functional classes of the 183 determinants of resistance to 5-flucytosine.

    No full text
    <p>A) Genes clustered according to the biological process taxonomy of Gene Ontology, using the GoToolBox software (<a href="http://genome.crg.es/GOToolBox/" target="_blank">http://genome.crg.es/GOToolBox/</a>). The most highly ranked statistically significant (p-value<0.01) GO terms are displayed. The gene frequency within each class is indicated by the black bars, compared to the frequency registered for the <i>S</i>. <i>cerevisiae</i> whole genome, indicated by the grey bars, gene frequency being the percentage of the genes in a list associated to a specific GO terms. B) Classification based on the description of gene function registered in the Saccharomyces Genome Database (<a href="http://www.yeastgenome.org/" target="_blank">www.yeastgenome.org</a>). The genes that fall into each class are detailed in supplementary <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0135110#pone.0135110.s002" target="_blank">S1 Table</a>.</p
    corecore